Mubadala Announces $600 Million Investment in Nord Anglia Education Joining a Consortium led by EQT

Abu Dhabi, UAE – 17 April 2025 – Mubadala Investment Company, the Abu Dhabi-based investment company, announced its agreement to acquire a minority stake in Nord Anglia Education, a leading international schools organization for $600 million. Mubadala will join the consortium led by global investment organization EQT which includes Neuberger Berman, Canada Pension Plan Investment Board, Corporación Financiera Alba, S.A., and Dubai Holding.

Continue reading Mubadala Announces $600 Million Investment in Nord Anglia Education Joining a Consortium led by EQT

M42’s NRL and Neurocode International launch region-first Center for Advanced Neuro Biochemical Diagnostics

  • Equipped with world-class laboratory equipment and staffed by renowned neurologists and pathologists, the Center for Advanced Neuro Biochemical Diagnostics will offer non-invasive testing for patients as young as 40, enabling early detection and helping reduce Alzheimer’s cases in the UAE and the wider region

Abu Dhabi, United Arab Emirates. April 16, 2025: Setting a new regional benchmark in the fight against Alzheimer’s disease, the National Reference Laboratory (NRL), part of the M42 Group, is establishing the MENA region’s first Center for Advanced Neuro Biochemical Diagnostics dedicated to early detection, in partnership with Neurocode International, global leader of neurology diagnostic solutions. Announced on the sidelines of Abu Dhabi Global Health Week, this Center for Advanced Neuro Biochemical Diagnostics, based in Abu Dhabi, is a pioneering step toward reducing Alzheimer’s cases in the UAE and wider region and transforming neurological diagnostics worldwide.

Continue reading M42’s NRL and Neurocode International launch region-first Center for Advanced Neuro Biochemical Diagnostics

DoH Fortifies Global Healthcare Ties with Five Strategic MoUs Signed with Russian Institutions during ADGHW

Further strengthening bilateral healthcare partnerships between both nations,

These agreements are the culmination of a strategic DoH delegation visit to Russia earlier this year

  • This collaborative approach drives innovation and enhances healthcare outcomes for populations worldwide, further positioning Abu Dhabi as a global life sciences hub and an incubator for responsible healthcare innovation
  • The agreements between the DoH and the five leading Russian entities seek to synergise efforts in innovative clinical trials, enhance medical research and capacity-building initiatives, underpinned by cross-disciplinary knowledge exchange
Continue reading DoH Fortifies Global Healthcare Ties with Five Strategic MoUs Signed with Russian Institutions during ADGHW

Infinite Reality To Acquire Agentic AI Company Touchcast For $500M In A Deal That Values Infinite Reality At $15.5B

Touchcast’s AI technology to be integrated with Infinite Reality’s portfolio of products and services including Napster, iR Studio, and iR Enterprise

Dubai, UAE — April 16, 2025Infinite Reality™ (iR), an innovation company powering the next generation of digital media and ecommerce through extended reality (XR), artificial intelligence (AI), and other immersive technologies, announced today the company has entered into a definitive agreement to acquire Touchcast, a pioneering agentic AI company for $500 million in a combination of cash and stock. The acquisition is Infinite Reality’s largest yet, and the transaction agreement values the company at $15.5 billion.

Continue reading Infinite Reality To Acquire Agentic AI Company Touchcast For $500M In A Deal That Values Infinite Reality At $15.5B

As part of Abu Dhabi’s Health, Endurance, Longevity, and Medicine cluster,

DoH and ADIO partner with Unilabs to Establish Advanced Analytical Laboratory for Clinical Research

  • By working hand-in-hand with ADIO and Unilabs, the Department remains dedicated to providing innovative treatments and breakthrough solutions in the UAE and around the world

Abu Dhabi, UAE 16 April 2025:The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and the Abu Dhabi Investment Office (ADIO) have signed a Memorandum of Understanding (MoU) with Unilabs Pharma Solutions, a subsidiary of leading international provider of diagnostic services Unilabs, on the sidelines of Abu Dhabi Global Healthcare Week 2025 (ADGHW).  Under the agreement, the parties aim to develop a state-of-the-art analytical laboratory as part of Abu Dhabi’s recently launched Health, Endurance, Longevity, and Medicine (HELM) cluster, a pioneering hub for biotechnology, MedTech and digital health innovation.

Continue reading As part of Abu Dhabi’s Health, Endurance, Longevity, and Medicine cluster,